Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

“Nothing else is even close.” Musk first revealed he had shed pounds using a weight-loss drug in October 2022. When about his “secret” to getting a “ripped” physique quickly, the ...

21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been ... weight-loss medications more than doubled between 2022 and 2023. Meanwhile, they have also been found to ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly “opens the possibility of an end to the obesity pandemic” alongside other interventions, the World Health Organization (WHO) ...

Also in today’s edition: ‘no-show’ international student data and significant progress in Israel-Hamas ceasefire talks ...

The research shows the percentage of adults with obesity dropped from 46% in 2022 ... of new weight loss medications called GLP-1 receptor agonists, including semaglutide-based drugs like Ozempic ...